Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | UBE2E2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
mRNA | NARF | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | CAMP | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
mRNA | SP5 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
mRNA | ERCC6L2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
mRNA | KCNH2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
mRNA | MMP20 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
mRNA | AC002985.3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
mRNA | ALPK2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
mRNA | KYAT3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |